Immunocore Holdings (IMCR) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Immunocore Holdings (IMCR) over the last 3 years, with Q3 2025 value amounting to -$0.0.
- Immunocore Holdings' EPS (Weighted Average and Diluted) fell 10228.74% to -$0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.57, marking a year-over-year increase of 4000.0%. This contributed to the annual value of -$1.02 for FY2024, which is 956.44% up from last year.
- Per Immunocore Holdings' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.0 for Q3 2025, which was down 10228.74% from -$0.2 recorded in Q2 2025.
- Over the past 5 years, Immunocore Holdings' EPS (Weighted Average and Diluted) peaked at $0.17 during Q3 2024, and registered a low of -$0.49 during Q1 2024.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$0.21, with a median of -$0.23 in 2024.
- In the last 5 years, Immunocore Holdings' EPS (Weighted Average and Diluted) soared by 75000.0% in 2024 and then tumbled by 10228.74% in 2025.
- Quarter analysis of 3 years shows Immunocore Holdings' EPS (Weighted Average and Diluted) stood at -$0.4 in 2023, then dropped by 18.88% to -$0.48 in 2024, then soared by 99.18% to -$0.0 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.0 in Q3 2025, compared to -$0.2 in Q2 2025 and $0.1 in Q1 2025.